Current Role of Echinocandins in the Management of Invasive Aspergillosis

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration

(2011) J. M. Leitner et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies

(2010) Naoe Goto et al.   AMERICAN JOURNAL OF HEMATOLOGY

In VitroActivity andIn VivoEfficacy of Anidulafungin in Murine Infections byAspergillus flavus

(2010) Enrique Calvo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study

(2010) Parinda A. Mehta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry

(2010) Johan Maertens et al.   BMC INFECTIOUS DISEASES

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

(2010) R Herbrecht et al.   BONE MARROW TRANSPLANTATION

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?

(2010) Coralia N. Mihu et al.   CANCER

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

(2010) David W. Kubiak et al.   CLINICAL THERAPEUTICS

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

(2010) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Echinocandin Antifungal Drugs in Fungal Infections

(2010) Sharon C.-A. Chen et al.   DRUGS

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort

(2010) J. W. Hiemenz et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

A Case of Aspergillus Empyema Successfully Treated with Combination Therapy of Voriconazole and Micafungin: Excellent Penetration of Voriconazole and Micafungin into Pleural Fluid

(2010) Toshiaki Matsuda et al.   INTERNAL MEDICINE

Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies

(2010) Yuji Hirata et al.   LEUKEMIA & LYMPHOMA

Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients

(2010) Heinrich Lellek et al.   MYCOSES

A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

(2010) Johan A. Maertens et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis

(2009) V. Petraitis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin

(2009) W. W. J. van de Sande et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

(2009) Corrado Girmenia et al.   CLINICAL INFECTIOUS DISEASES

High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia

(2009) M. Lafaurie et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea

(2009) Hyun Soon Sohn et al.   CLINICAL THERAPEUTICS

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry

(2009) Jörg J. Vehreschild et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

(2009) C. Viscoli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia

(2009) D. Al-Badriyeh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders

(2009) Kazuo Tamura et al.   LEUKEMIA & LYMPHOMA

Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B againstAspergillusspp.

(2009) Joanne P. Demchok et al.   MYCOSES

Antifungal prophylaxis with micafungin in patients treated for childhood cancer

(2009) Shigenori Kusuki et al.   PEDIATRIC BLOOD & CANCER

A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented Candida or Aspergillus Infections in Pediatric Patients

(2009) T. E. Zaoutis et al.   PEDIATRICS

A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients

(2008) Christina T. Rieger et al.   ANNALS OF HEMATOLOGY

When Primary Antifungal Therapy Fails

(2008) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Invasive aspergillosis: diagnosis, prophylaxis and treatment

(2008) Valerio Del Bono et al.   CURRENT OPINION IN HEMATOLOGY

In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi

(2008) Mery Ruíz-Cendoya et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

(2008) Yasushi Hiramatsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Role of (1→3)-β-D-glucan in the diagnosis of invasive aspergillosis

(2008) Francisco M. Marty et al.   MEDICAL MYCOLOGY

Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis

(2008) D.P. Kontoyiannis et al.   Transplant Infectious Disease